OSTEOPOROSIS
Clinical trials for OSTEOPOROSIS explained in plain language.
Never miss a new study
Get alerted when new OSTEOPOROSIS trials appear
Sign up with your email to follow new studies for OSTEOPOROSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a common cholesterol drug protect bones and hearts after spinal injury?
Disease control TerminatedThis study tested whether the statin drug rosuvastatin, taken daily with supplements, could improve bone density and reduce heart disease risk in adults with long-term spinal cord injury. Only 8 people enrolled before the trial was stopped early. Participants received either rosu…
Matched conditions: OSTEOPOROSIS
Phase: PHASE2 • Sponsor: Dr. B. Catharine. Craven • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
HIV drugs may weaken bones: new study investigates
Knowledge-focused TerminatedThis study looked at bone density in HIV-positive men to see if antiretroviral drugs cause bone thinning. Researchers compared men starting HIV treatment with those not yet on therapy over two years. The goal was to understand why bone loss is more common in HIV patients.
Matched conditions: OSTEOPOROSIS
Phase: NA • Sponsor: University Hospital, Strasbourg, France • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:51 UTC